Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13278 | 783 | 33.9 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2281 | 4192 | ANGIOGENIN//RIBONUCLEASE//RIBONUCLEASE INHIBITOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DEOXYRIBONUCLEASE I | Author keyword | 32 | 58% | 5% | 37 |
2 | L DNASE II | Author keyword | 30 | 100% | 2% | 12 |
3 | MED GENET BIOCHEM | Address | 26 | 51% | 5% | 36 |
4 | DNASE1 | Author keyword | 21 | 85% | 1% | 11 |
5 | DNASE II | Author keyword | 17 | 59% | 2% | 19 |
6 | DEOXYRIBONUCLEASE I DNASE I | Author keyword | 15 | 82% | 1% | 9 |
7 | DEOXYRIBONUCLEASE | Author keyword | 15 | 41% | 4% | 28 |
8 | DNASE I | Author keyword | 11 | 25% | 5% | 39 |
9 | CIDE DOMAIN | Author keyword | 11 | 100% | 1% | 6 |
10 | DFF45 | Author keyword | 10 | 52% | 2% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DEOXYRIBONUCLEASE I | 32 | 58% | 5% | 37 | Search DEOXYRIBONUCLEASE+I | Search DEOXYRIBONUCLEASE+I |
2 | L DNASE II | 30 | 100% | 2% | 12 | Search L+DNASE+II | Search L+DNASE+II |
3 | DNASE1 | 21 | 85% | 1% | 11 | Search DNASE1 | Search DNASE1 |
4 | DNASE II | 17 | 59% | 2% | 19 | Search DNASE+II | Search DNASE+II |
5 | DEOXYRIBONUCLEASE I DNASE I | 15 | 82% | 1% | 9 | Search DEOXYRIBONUCLEASE+I+DNASE+I | Search DEOXYRIBONUCLEASE+I+DNASE+I |
6 | DEOXYRIBONUCLEASE | 15 | 41% | 4% | 28 | Search DEOXYRIBONUCLEASE | Search DEOXYRIBONUCLEASE |
7 | DNASE I | 11 | 25% | 5% | 39 | Search DNASE+I | Search DNASE+I |
8 | CIDE DOMAIN | 11 | 100% | 1% | 6 | Search CIDE+DOMAIN | Search CIDE+DOMAIN |
9 | DFF45 | 10 | 52% | 2% | 13 | Search DFF45 | Search DFF45 |
10 | NUC 1 | 8 | 75% | 1% | 6 | Search NUC+1 | Search NUC+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CASPASE ACTIVATED DNASE | 68 | 45% | 15% | 115 |
2 | PORCINE SPLEEN DEOXYRIBONUCLEASE | 45 | 94% | 2% | 16 |
3 | FRAGMENTATION FACTOR | 35 | 72% | 4% | 28 |
4 | ICAD | 35 | 86% | 2% | 18 |
5 | HUMAN DEOXYRIBONUCLEASE II | 31 | 82% | 2% | 18 |
6 | BOVINE PANCREATIC DEOXYRIBONUCLEASE | 24 | 61% | 3% | 25 |
7 | GENETICALLY POLYMORPHIC DEOXYRIBONUCLEASE | 21 | 90% | 1% | 9 |
8 | DFF40 | 17 | 100% | 1% | 8 |
9 | DNASE II | 16 | 51% | 3% | 23 |
10 | HUMAN XQ28 | 16 | 64% | 2% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Degradation of chromosomal DNA during apoptosis | 2003 | 189 | 98 | 54% |
Apoptotic DNA fragmentation | 2000 | 493 | 52 | 37% |
Trashing the genome: The role of nucleases during apoptosis | 2005 | 134 | 132 | 50% |
Comparative biochemical properties of vertebrate deoxyribonuclease I | 2012 | 4 | 43 | 86% |
Apoptotic DNA fragmentation and tissue homeostasis | 2002 | 68 | 54 | 59% |
DNase II: genes, enzymes and function | 2003 | 101 | 65 | 46% |
Roles of the Major Apoptotic Nuclease-DNA Fragmentation Factor-in Biology and Disease | 2009 | 34 | 109 | 58% |
Cuts can kill: the roles of apoptotic nucleases in cell death and animal development | 2006 | 28 | 61 | 54% |
Nucleases in programmed cell death | 2008 | 19 | 42 | 45% |
DNA degradation in development and programmed cell death | 2005 | 129 | 105 | 31% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED GENET BIOCHEM | 26 | 51% | 4.6% | 36 |
2 | ABT ANAT EMBRYOL | 3 | 26% | 1.3% | 10 |
3 | OLD CIVIL HOSP GUADALAJARA | 3 | 60% | 0.4% | 3 |
4 | CELL DEATH SENESCENCE SURVIVAL GRP | 2 | 44% | 0.5% | 4 |
5 | EXPT CLIN RADIOBIOL | 2 | 16% | 1.3% | 10 |
6 | PITTSBURGH NEURODEGENERAT DISORDERS | 2 | 43% | 0.4% | 3 |
7 | COMPREHENS HEART FAILURE CHCF | 1 | 100% | 0.3% | 2 |
8 | LEGAL MED MED GENET | 1 | 100% | 0.3% | 2 |
9 | U 598 | 1 | 50% | 0.3% | 2 |
10 | U872 EQ 17 | 1 | 100% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000234099 | ENDO EXONUCLEASE//EXTRACELLULAR NUCLEASE//EXTRACELLULAR ENDONUCLEASE |
2 | 0.0000145663 | HIGH MOLECULAR WEIGHT DNA FRAGMENTATION//CA2 MG2 DEPENDENT ENDONUCLEASE//APO27 |
3 | 0.0000133003 | APOPTOSIS INDUCING FACTOR//AIF//AMID |
4 | 0.0000091491 | APAF 1//CASPASE 2//RAIDD |
5 | 0.0000070484 | ARCTIC HABITATS//ANTISTAPHYLOCOCCAL ACTIVITIES//CYCLO L LEU L ARG |
6 | 0.0000070219 | NEUTROPHIL EXTRACELLULAR TRAPS//NEUTROPHIL EXTRACELLULAR TRAP//NETOSIS |
7 | 0.0000055284 | MFG E8//APOPTOTIC CELLS//CELL CLEARANCE |
8 | 0.0000052806 | RHDNASE//DORNASE ALFA//MUCUS VISCOELASTICITY |
9 | 0.0000041202 | PARAPTOSIS//BAP31//MEMBRANE BLEBS |
10 | 0.0000037729 | ANGIOGENIN//RIBONUCLEASE INHIBITOR//ONCONASE |